Treatment Study in Patients Treated With Both Insulin & Hydrocortisone
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-70
SponsorVastra Gotaland Region
About this trial
The aim of INS.CORT trial is, by studying glycemic variability in a well-defined patient group with both insulin \& hydrocortisone (patients with concomitant insulin-treated diabetes \& Addison's disease) and collecting information about the administration -time point and doses- of insulin, hydrocortisone and food intake with the help of new technology to improve the treatment in all patients treated with both insulin \& glucocorticoids.
Eligibility criteria
Qualifiers
None
Disqualifiers
Any medication with other glucose lowering agents than insulin
Any additional underlying or intercurrent disease that may need regular or periodic pharmacological treatment with glucocorticoids during the study period, including infectious diseases
Any medication with agents which in the investigator's judgement might interfere with the study drugs kinetics, including therapies affecting gastrointestinal emptying or motility
Any medication with oral estrogen supplementation and/or regular DHEA medication for the past 4 weeks
Trial design
Treatments tested in this trial
- OD dual-release Hydrocortisone
- TID Hydrocortisone
Treatment groups
16 Participants
are divided into 2 treatment groupsSponsors and collaborators
Vastra Gotaland Region
Lead sponsor
The Swedish Society of Medicine
Collaborator
Åke Wibergs Stiftelse
Collaborator
Sahlgrenska University Hospital
Collaborator
Pilloxa
Collaborator
Source ClinicalTrials.gov